Brimonidine tartrate 0.33% gel for the management of posttreatment erythema induced by laser skin resurfacing

J Am Acad Dermatol. 2017 Feb;76(2):e53-e55. doi: 10.1016/j.jaad.2016.10.020.

Authors

Stephan Alexander Braun¹, Ofir Artzi², Peter Arne Gerber³

Affiliations

¹ Department of Dermatology, Heinrich-Heine University, Düsseldorf, Germany.
² Department of Dermatology, Sourasky Medical Center, Tel Aviv, Israel.
³ Department of Dermatology, Heinrich-Heine University, Düsseldorf, Germany. Electronic address: peterarne.gerber@med.uni-duesseldorf.de.

PMID: 28089013
DOI: 10.1016/j.jaad.2016.10.020

No abstract available

Keywords: carbon-dioxide; erbium:yttrium-aluminium-garnet; fractional ablative lasers; management; side effects; therapy.

Publication types

Case Reports

MeSH terms

Adrenergic alpha-2 Receptor Agonists / administration & dosage*
Adult
Brimonidine Tartrate / administration & dosage*
Cosmetic Techniques / adverse effects*
Erythema / drug therapy*
Erythema / etiology*
Female
Gels
Humans
Laser Therapy / adverse effects*

Substances

Adrenergic alpha-2 Receptor Agonists
Gels
Brimonidine Tartrate